Down-regulation of secreted lymphocyte antigen-6/urokinase-type plasminogen activator receptor-related peptide-1 (SLURP-1), an endogenous allosteric α7 nicotinic acetylcholine receptor modulator, in murine and human asthmatic conditions

Osamu Narumoto, Kazuhide Horiguchi, Satomi Horiguchi, Yasuhiro Moriwaki, Hiromi Takano-Ohmuro, Shunsuke Shoji, Hidemi Misawa, Naohide Yamashita, Takahide Nagase, Koichiro Kawashima, Naomi Yamashita

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Whereas acetylcholine (ACh) acts as a bronchoconstrictor and stimulator of mucus secretion from bronchial epithelium, it acts via α7 nicotinic Ach receptors (nAChRs) on macrophages in the airways to exert anti-inflammatory effects by reducing synthesis of pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α). Moreover, the effects of ACh are modified by secreted ly-6/urokinase-type plasminogen activator receptor-related peptide-1 (SLURP-1), a positive allosteric modulator of α7 nAChR signaling. Our aim was to explore the roles played by SLURP-1 in the pathophysiology of asthma by assessing SLURP-1 expression in the OVA-sensitized murine asthma model and in cultured human bronchial epithelial cells. Using real-time PCR we found that expression of SLURP-1 mRNA is down-regulated in the lungs of asthmatic model mice, as compared to healthy mice. In addition, immunohistochemical studies confirmed the diminished expression of SLURP-1 in the bronchioles of asthmatic mice, and showed it was due to extensive metaplasia of mucus-secreting cells and the concomitant loss of ciliated epithelial cells. Expression of SLURP-1 mRNA and protein was also significantly down-regulated in human epithelial cells stimulated with the pro-inflammatory cytokine interleukin-13 (IL-13), which is related to asthmatic condition. Thus SLURP-1 appears to be down-regulated in both an animal model of asthma and human epithelial cells treated with an inflammatory cytokine related to asthma. Those findings suggest that diminished expression of SLURP-1 in asthma attenuates its negative regulation of airway inflammation, and that perhaps changes in SLURP-1 expression could serve as a marker of airway damage in asthma.

Original languageEnglish
Pages (from-to)713-718
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume398
Issue number4
DOIs
Publication statusPublished - 2010 Aug

Fingerprint

Urokinase Plasminogen Activator Receptors
Lymphocytes
Nicotinic Receptors
Modulators
Down-Regulation
Asthma
Antigens
Peptides
Cytokines
Epithelial Cells
Acetylcholine
Bronchoconstrictor Agents
Mucus
Messenger RNA
Interleukin-13
Macrophages
Bronchioles
Animals
Anti-Inflammatory Agents
Tumor Necrosis Factor-alpha

Keywords

  • Acetylcholine
  • Asthma
  • Bronchial epithelial cells
  • Mucus-secreting cells
  • Nicotinic receptors

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Down-regulation of secreted lymphocyte antigen-6/urokinase-type plasminogen activator receptor-related peptide-1 (SLURP-1), an endogenous allosteric α7 nicotinic acetylcholine receptor modulator, in murine and human asthmatic conditions. / Narumoto, Osamu; Horiguchi, Kazuhide; Horiguchi, Satomi; Moriwaki, Yasuhiro; Takano-Ohmuro, Hiromi; Shoji, Shunsuke; Misawa, Hidemi; Yamashita, Naohide; Nagase, Takahide; Kawashima, Koichiro; Yamashita, Naomi.

In: Biochemical and Biophysical Research Communications, Vol. 398, No. 4, 08.2010, p. 713-718.

Research output: Contribution to journalArticle

Narumoto, Osamu ; Horiguchi, Kazuhide ; Horiguchi, Satomi ; Moriwaki, Yasuhiro ; Takano-Ohmuro, Hiromi ; Shoji, Shunsuke ; Misawa, Hidemi ; Yamashita, Naohide ; Nagase, Takahide ; Kawashima, Koichiro ; Yamashita, Naomi. / Down-regulation of secreted lymphocyte antigen-6/urokinase-type plasminogen activator receptor-related peptide-1 (SLURP-1), an endogenous allosteric α7 nicotinic acetylcholine receptor modulator, in murine and human asthmatic conditions. In: Biochemical and Biophysical Research Communications. 2010 ; Vol. 398, No. 4. pp. 713-718.
@article{3feeed55664b495cb89e5826d66a364d,
title = "Down-regulation of secreted lymphocyte antigen-6/urokinase-type plasminogen activator receptor-related peptide-1 (SLURP-1), an endogenous allosteric α7 nicotinic acetylcholine receptor modulator, in murine and human asthmatic conditions",
abstract = "Whereas acetylcholine (ACh) acts as a bronchoconstrictor and stimulator of mucus secretion from bronchial epithelium, it acts via α7 nicotinic Ach receptors (nAChRs) on macrophages in the airways to exert anti-inflammatory effects by reducing synthesis of pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α). Moreover, the effects of ACh are modified by secreted ly-6/urokinase-type plasminogen activator receptor-related peptide-1 (SLURP-1), a positive allosteric modulator of α7 nAChR signaling. Our aim was to explore the roles played by SLURP-1 in the pathophysiology of asthma by assessing SLURP-1 expression in the OVA-sensitized murine asthma model and in cultured human bronchial epithelial cells. Using real-time PCR we found that expression of SLURP-1 mRNA is down-regulated in the lungs of asthmatic model mice, as compared to healthy mice. In addition, immunohistochemical studies confirmed the diminished expression of SLURP-1 in the bronchioles of asthmatic mice, and showed it was due to extensive metaplasia of mucus-secreting cells and the concomitant loss of ciliated epithelial cells. Expression of SLURP-1 mRNA and protein was also significantly down-regulated in human epithelial cells stimulated with the pro-inflammatory cytokine interleukin-13 (IL-13), which is related to asthmatic condition. Thus SLURP-1 appears to be down-regulated in both an animal model of asthma and human epithelial cells treated with an inflammatory cytokine related to asthma. Those findings suggest that diminished expression of SLURP-1 in asthma attenuates its negative regulation of airway inflammation, and that perhaps changes in SLURP-1 expression could serve as a marker of airway damage in asthma.",
keywords = "Acetylcholine, Asthma, Bronchial epithelial cells, Mucus-secreting cells, Nicotinic receptors",
author = "Osamu Narumoto and Kazuhide Horiguchi and Satomi Horiguchi and Yasuhiro Moriwaki and Hiromi Takano-Ohmuro and Shunsuke Shoji and Hidemi Misawa and Naohide Yamashita and Takahide Nagase and Koichiro Kawashima and Naomi Yamashita",
year = "2010",
month = "8",
doi = "10.1016/j.bbrc.2010.07.006",
language = "English",
volume = "398",
pages = "713--718",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Down-regulation of secreted lymphocyte antigen-6/urokinase-type plasminogen activator receptor-related peptide-1 (SLURP-1), an endogenous allosteric α7 nicotinic acetylcholine receptor modulator, in murine and human asthmatic conditions

AU - Narumoto, Osamu

AU - Horiguchi, Kazuhide

AU - Horiguchi, Satomi

AU - Moriwaki, Yasuhiro

AU - Takano-Ohmuro, Hiromi

AU - Shoji, Shunsuke

AU - Misawa, Hidemi

AU - Yamashita, Naohide

AU - Nagase, Takahide

AU - Kawashima, Koichiro

AU - Yamashita, Naomi

PY - 2010/8

Y1 - 2010/8

N2 - Whereas acetylcholine (ACh) acts as a bronchoconstrictor and stimulator of mucus secretion from bronchial epithelium, it acts via α7 nicotinic Ach receptors (nAChRs) on macrophages in the airways to exert anti-inflammatory effects by reducing synthesis of pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α). Moreover, the effects of ACh are modified by secreted ly-6/urokinase-type plasminogen activator receptor-related peptide-1 (SLURP-1), a positive allosteric modulator of α7 nAChR signaling. Our aim was to explore the roles played by SLURP-1 in the pathophysiology of asthma by assessing SLURP-1 expression in the OVA-sensitized murine asthma model and in cultured human bronchial epithelial cells. Using real-time PCR we found that expression of SLURP-1 mRNA is down-regulated in the lungs of asthmatic model mice, as compared to healthy mice. In addition, immunohistochemical studies confirmed the diminished expression of SLURP-1 in the bronchioles of asthmatic mice, and showed it was due to extensive metaplasia of mucus-secreting cells and the concomitant loss of ciliated epithelial cells. Expression of SLURP-1 mRNA and protein was also significantly down-regulated in human epithelial cells stimulated with the pro-inflammatory cytokine interleukin-13 (IL-13), which is related to asthmatic condition. Thus SLURP-1 appears to be down-regulated in both an animal model of asthma and human epithelial cells treated with an inflammatory cytokine related to asthma. Those findings suggest that diminished expression of SLURP-1 in asthma attenuates its negative regulation of airway inflammation, and that perhaps changes in SLURP-1 expression could serve as a marker of airway damage in asthma.

AB - Whereas acetylcholine (ACh) acts as a bronchoconstrictor and stimulator of mucus secretion from bronchial epithelium, it acts via α7 nicotinic Ach receptors (nAChRs) on macrophages in the airways to exert anti-inflammatory effects by reducing synthesis of pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α). Moreover, the effects of ACh are modified by secreted ly-6/urokinase-type plasminogen activator receptor-related peptide-1 (SLURP-1), a positive allosteric modulator of α7 nAChR signaling. Our aim was to explore the roles played by SLURP-1 in the pathophysiology of asthma by assessing SLURP-1 expression in the OVA-sensitized murine asthma model and in cultured human bronchial epithelial cells. Using real-time PCR we found that expression of SLURP-1 mRNA is down-regulated in the lungs of asthmatic model mice, as compared to healthy mice. In addition, immunohistochemical studies confirmed the diminished expression of SLURP-1 in the bronchioles of asthmatic mice, and showed it was due to extensive metaplasia of mucus-secreting cells and the concomitant loss of ciliated epithelial cells. Expression of SLURP-1 mRNA and protein was also significantly down-regulated in human epithelial cells stimulated with the pro-inflammatory cytokine interleukin-13 (IL-13), which is related to asthmatic condition. Thus SLURP-1 appears to be down-regulated in both an animal model of asthma and human epithelial cells treated with an inflammatory cytokine related to asthma. Those findings suggest that diminished expression of SLURP-1 in asthma attenuates its negative regulation of airway inflammation, and that perhaps changes in SLURP-1 expression could serve as a marker of airway damage in asthma.

KW - Acetylcholine

KW - Asthma

KW - Bronchial epithelial cells

KW - Mucus-secreting cells

KW - Nicotinic receptors

UR - http://www.scopus.com/inward/record.url?scp=77955418129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955418129&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2010.07.006

DO - 10.1016/j.bbrc.2010.07.006

M3 - Article

C2 - 20621062

AN - SCOPUS:77955418129

VL - 398

SP - 713

EP - 718

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -